Applying Lessons Learned From COVID-19 Therapeutic Trials to Improve Future ALI/ARDS Trials

Host-directed therapeutics targeting immune dysregulation are considered the most promising approach to address the unmet clinical need for acute lung injury (ALI)/acute respiratory distress syndrome (ARDS) related to coronavirus disease 2019 (COVID-19). To better understand the current clinical stu...

Descripción completa

Detalles Bibliográficos
Autores principales: Wu, Qun, Pennini, Meghan E, Bergmann, Julie N, Kozak, Marina L, Herring, Kristen, Sciarretta, Kimberly L, Armstrong, Kimberly L
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2022
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9379817/
https://www.ncbi.nlm.nih.gov/pubmed/35983268
http://dx.doi.org/10.1093/ofid/ofac381

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9379817/
https://www.ncbi.nlm.nih.gov/pubmed/35983268
http://dx.doi.org/10.1093/ofid/ofac381

Ejemplares similares